RRM1 expression in tissue microarray and prognosis analysis in non-small cell lung cancer

Chinese Journal of Lung Cancer

Volumn 9, Issue 5, 2006, Pages 423-427

  Liao, Riqiang ^a   Lin, Jiayin ^a   Qiao, Guibin ^a   Luo, Xinlan ^a   Yang, Jingji ^a   Huang, Yujuan ^a   Wu, Yilong ^a  

^a GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Non small cell lung cancer; Prognosis; RRM1; Tissue microarray

Indexed keywords

RIBONUCLEOTIDE REDUCTASE; RIBONUCLEOTIDE REDUCTASE SUBUNIT M1; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; INFANT; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PROGNOSIS; PROTEIN EXPRESSION; TISSUE MICROARRAY; UNIVARIATE ANALYSIS;

EID: 33750445336     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest, 1997, 111(6): 1710-1717.
2. Wu YL ed. Lung cancer-principles, practice of multidisciplinary synthetic therapy. Beijing; People's Medical Publishing House, 2000, 26-27.
3. Qiao GB, Wu YL, Ou W, et al. Reliability of tissue microarrays for immunohistochemical detecting of tumor markers in non-small cell lung cancer. Cancer Res Prev Treat, 2004, 31(8): 467-470.
4. Brundage MD, Davies D, Mackillop WJ. Prognostic factors in non-small cell lung cancer: a decade of progress. Chest, 2002, 122(3): 1037-1057.
5. Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med, 1998, 4(7): 844-847.
6. Ranzani GN, Renault B, Pellegata NS, et al. Loss of heterozygosity and K-ras gene mutations in gastric cancer. Hum Genet, 1993, 92(3): 244-249.
7. Shibagaki I, Shimada Y, Wagata T, et al. Allelotype analysis of esophageal squamous cell carcinoma. Cancer Res, 1994, 54(11): 2996-3000.
8. Ali IU, Lidereau R, Theillet C, et al. Reduction to homozygosity of genes on chromosome 11 in human breast neoplasia. Science, 1987, 238(4824): 185-188.
9. Tran YK, Newsham IF. High-density marker analysis of 11p15.5 in non-small cell lung carcinomas reveals allelic deletion of one shared and one distinct region when compared to breast carcinomas. Cancer Res, 1996, 56(13): 2916-2921.
10. Bepler G, Fong KM, Johnson BE, et al. Association of chromosome 11 locus D11S12 with histology, stage, and metastases in lung cancer. Cancer Detect Prev, 1998, 22(1): 14-19.
11. O'Briant KC, Bepler G. Delineation of the centromeric and telomeric chromosome segment 11p15.5 lung cancer suppressor regions LOH11A and LOH11B. Genes Chromosomes Cancer, 1997, 18 (2): 111-114.
12. Satoh H, Lamb PW, Dong JT, et al. Suppression of tumorigenicity of A549 lung adenocarcinoma cells by human chromosomes 3 and 11 introduced via microcell-mediated chromosome transfer. Mol Carcinog, 1993, 7(3): 157-164.
13. Bepler G, Gautam A, Simon G, et al. PTEN, RRM1, and ERCC1 are coexpressed in non-small-cell lung cancer (NSCLC) and are predictive of survival. Lung Cancer, 2003, 41(S2): 76.
14. Bepler G, Sharma S, Cantor A, et al. RRM1 and PTEN as prognostic parameters for overall and disease-free survival in patients with non-small-cell lung cancer. J Clin Oncol, 2004, 22(10): 1878-1885.
15. Bepler G, Sharma S, Gautam A, et al. Tumor genotype, RRM1 expression, and outcome of patients with lung cancer. Eur J Cancer, 2003, 38(37): S82-S83.
16. Rosell R, Scagliotti G, Danenberg KD, et al. Transcripts in pretreatment biopsies from a three-arm randomized trial in metastatic non-small-cell lung cancer. Oncogene, 2003, 22(23): 3548-3553.
17. Rosell R, Danenberg KD, Alberola V, et al; Spanish Lung Cancer Group. Ribonucleotide reductase messenger RNA expression and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients. Clin Cancer Res, 2004, 10(4): 1318-1325.